Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Rubius Therapeutics Inc. buy me8

Rubius Therapeutics Inc.
Start price
€8.20
14.12.20 / 50%
Target price
€11.00
14.12.21
Performance (%)
15.85%
End price
€9.50
29.01.21
Summary
This prediction ended on 29.01.21 with a price of €9.50. The BUY prediction by me8 finished with a performance of 15.85%. me8 has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Rubius Therapeutics Inc. - - - -
iShares Core DAX® 4.015% 2.971% 16.492% 19.144%
iShares Nasdaq 100 2.755% 0.503% 40.029% 50.636%
iShares Nikkei 225® -0.826% -5.057% 14.566% 2.379%
iShares S&P 500 2.330% 0.720% 30.194% 44.181%

According to me8 what are the pros and cons of Rubius Therapeutics Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Very capable Management
Good culture
Top 10 in its market
Cons
Sustainability is little important
Higher risks for its business

Comments by me8 for this prediction

In the thread Rubius Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 15.85%
Target price 11.000
Change
Ends at 14.12.21

Buy mit Kursziel 11,0

me8 
0
Report Share
14.12.20
In the thread Trading Rubius Therapeutics Inc.
Prediction Buy
Perf. (%) 15.85%
Target price 11.000
Change
Ends at 14.12.21

Buy beendet

me8 
0
Report Share
29.01.21

Stopped prediction by me8 for Rubius Therapeutics Inc.

buy
Rubius Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.14
04.09.22
-
04.09.23
-92.50%
05.09.23

Could be worthwhile Investment >10% per year
Very capable Management
Good culture
Sustainability is little important
me8 
04.09.22 0%